Home

Cash is King

After several weeks of lower stock prices, the market this past week decided that the looming bankruptcy of the world's largest real estate debt...

TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus...

TW's Take: very positive data. Inhaled tacrolimus is showing itself to be everything TFF claims for their products; equally efficacy at lower doses, resulting...

Trading Blog, Sept. 22nd, 2021

~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to...

Hancock Jaffe Announces Corporate Rebranding to Reflect Prioritization of its Development Pipeline on Venous...

TW's Take: while the news out of HJLI is not earth-shattering, the conference call was very bullish. It appears the opportunity in front of...

Ondas Networks to Present at Annual Railway System Supplier Show

TW's Take: Ondas will be in the Siemens booth at the show. We look forward to seeing just how big a push Siemens is...

When The Tide Goes Out, You See Who’s Swimming Naked…

The markets had another downward-trending week since the last newsletter. However, the overall tone of the market felt better from a micro-cap investing standpoint...

Trading Blog, Sept. 16th, 2021

~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to...

Siemens Mobility to present Airlink Wireless Radio System in Live DemoCast

TW's Take: positive news for Ondas as their relationship with Siemens is key to driving the railroad business. A nice endorsement indeed. NANTUCKET, MA /...

Anixa Biosciences’ Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for...

TW's Take: as this promising treatment moves into the clinic later this year, there will be increased attention paid to Anixa and their partner,...

Amryt Raises Full Year 2021 Revenue Guidance to $220M – $225M

TW's Take: good news that we expected would come as the Company continues to execute very well. The Chiasma acquisition will lead to much...

Rolling Over? Markets Look Toppy To Me…

As I wrote about last week, we are entering what is historically the worst stretch of time for the market. I'm not sure why...

Trade Alert, Sept. 8, 2021

~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to...

Hancock Jaffe Laboratories Announces $20 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules

TW's Take: while the Company didn't need the money at this time, bringing on board Perceptive Advisors, which is probably the best healthcare fund...

Anixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer

TW's Take: Nice to see Dr. Kumar begin to build out the team around himself. Anixa is about to get very busy with two...

LexaGene’s MiQLab™ Accurately Detects Multiple Strains of Pathogenic Bacteria in Polymicrobial Samples Compared to...

TW's Take: more positive news for the MiQLab, which is rapidly becoming the best in class product for veterinary lab use. BEVERLY, Mass. – September...

ParkerVision Secures Patent License and Settlement Agreement with Zyxel

TW's Take: this is yet more positive news as ParkerVision moves down the path in their much larger suits against Qualcomm and Intel. Very...

A September To Remember?

I read this week where someone said, "the short story is always sexier." There's certainly a lot of truth in that. Here in September...

LexaGene’s MiQLab(TM) System Featured at Three Key Veterinary Tradeshows

TW's Take: the veterinary market could grow into a cash cow for LexaGene over the next few years. We should start to see uptake...

Lantern Pharma Expands Management Team with Appointment of Two Leading Industry Executives to Support...

TW's Take: Lantern is making all the right moves to set themselves up for long-term success. DALLAS, Sept. 2, 2021 /PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a...

Alzheimer’s Patients Treated with INmune Bio’s XPro™ Show Reduction in CSF Phospho-Tau and Evidence...

TW's Take: outstanding that demonstrates XPro195 is very effective in clearing neuroinflammation and reducing biomarkers associated with declining cognition. Very important PR that positions...

Become a TW Research Member

All our articles are free for everyone to enjoy, however you must register as a user. Please take the time to sign up, it’s free and we do not share your information with anyone.

For those interested in receiving alerts when we buy or sell stocks for our managed accounts, you should consider becoming a premium subscriber. A premium subscription costs $500 per year and subscribers get emails about every transaction taken in our portfolios, including names that have yet to be added to the Tailwinds site.

SIGN ME UP

Receive Our Weekly Newsletter

Every Sunday we recap the market and consolidate the news from our universe. It’s free to subscribe. Just click on the link below.

Newsletter Signup

DFC Advisory Services LLC (dba TW Research Group) is an investment adviser. We are also compensated for publishing information on certain companies. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.